MAPT and Alzheimer disease: Only small dimers/oligomers of soluble Aβ are present in the brains of subjects with a familial Aβ deletion (ΔE22) (Osaka mutation, Δ693 in APP) [297], but no plaques are present even though tau pathology and cognitive decline follow the same time course as in AD patients with significant plaque burden [298].